Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Transplant Proc ; 50(2): 578-580, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29579857

ABSTRACT

BACKGROUND: Cytomegalovirus (CMV) is the most common viral infection after kidney transplantation and is associated with significant morbidity and mortality. Recent studies showed that CMV-specific CD8+ T cells play the crucial role in protection against CMV. The Quantiferon-CMV (QF-CMV) is an interferon gamma (IFN-γ) release assay (IGRA test) that measures the IFN-γ response to a range of T-cell epitopes of CMV. In the present study, we analyzed the clinical utility of QF-CMV assay to predict CMV infection in kidney transplant recipients and evaluated if reactive result in QF-CMV test could be predictor of the duration of treatment. METHODS: We studied 75 renal transplant recipients who had IGRA testing just before transplantation. The donor and recipient variables were reported from the clinical history. The variables related to transplantation were collected from transplantation process data and included CMV infection or disease, CMV treatment, and immunosuppressive treatment. Laboratory variables were C3-C4 complement fractions and DNA quantification of CMV. RESULTS: Fifty percent of patients had CMV infection, and 35.9% had CMV disease. The time of negativization of CMV DNA was 56.61 ± 23.5 days. Univariate analysis related to CMV infection only showed a statistically significant relation with thymoglobulin treatment (P = .001). Statistically significant variables in relation with CMV infection incidence were donor serology (P = .044) and thymoglobulin treatment (P = .004). The probability of CMV infection was lower with positive IGRA assay (P = .025). CONCLUSION: We found that IFN-γ response measured by QF-MV is a protective factor against CMV infection in post-transplantation kidney recipients.


Subject(s)
Cytomegalovirus Infections/diagnosis , Cytomegalovirus/immunology , Interferon-gamma Release Tests/methods , Interferon-gamma/immunology , Postoperative Complications/diagnosis , Adult , CD8-Positive T-Lymphocytes/virology , Cytomegalovirus/genetics , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/virology , DNA, Viral/immunology , Female , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Kidney Transplantation/adverse effects , Male , Middle Aged , Postoperative Complications/epidemiology , Postoperative Complications/virology
2.
Transplant Proc ; 45(10): 3620-3, 2013.
Article in English | MEDLINE | ID: mdl-24314976

ABSTRACT

BACKGROUND: Infectious disease, a complication favored by immunosuppression, is the main cause of 1st-year mortality in solid organ transplantation. In renal transplant recipients (RTRs), urinary tract infection (UTI) is the most common, and the microorganisms that are isolated depend on chronology. METHODS: We present an observational study comprising 129 RTRs from January 2010 to December 2011 who were followed during the 1st year after transplantation. We analyzed occurrence of infections, predisposing factors, timing, severity, site of infection, and microorganisms. RESULTS: The patients had a total of 424 infectious episodes during the 1st year (3.29 episodes/patient/year). The predominant focus was the urinary tract, with at least 1 episode in 69.8% of patients. Bacteremia was recorded in 25.6% of patients and surgical wound infection in 20.9%. Cytomegalovirus infection or disease was diagnosed in 46.5%. Severe infections occurred in 30.2%. The predominant pathogen was E. coli. There was a significant correlation between hospital stay and the number of infections (P = .000; r = 0.407) and between body mass index and hospital stay (P = .001; r = 0.282). Severe infections were more frequent in diabetics, patients with a double-J stent, and those treated with basiliximab. Patients with cytomegalovirus replication had a higher number of infections (4.1 ± 1.2 vs 2.5 ± 5; P = .000) and significantly higher annual serum creatinine (1.65 ± 5.7 vs 1.31 ± 1.3 mg/dL; P = .003). CONCLUSIONS: The prevalence of infections in the 1st year after kidney transplantation is very high, occurring mainly in the early period, in the urinary tract, and due to E. coli. Cytomegalovirus replication is associated with a higher number of infections and higher serum creatinine at 1 year. Body mass index is a predictor of early infection and of bacteremia in the post-transplantation period. Basiliximab induction and having a double-J stent were predictors of severe infections.


Subject(s)
Communicable Diseases/epidemiology , Kidney Transplantation/adverse effects , Adult , Antibodies, Monoclonal/adverse effects , Basiliximab , Biomarkers/blood , Body Mass Index , Communicable Diseases/diagnosis , Communicable Diseases/microbiology , Communicable Diseases/virology , Creatinine/blood , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/virology , Diabetes Complications/etiology , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Humans , Immunosuppressive Agents/adverse effects , Length of Stay , Male , Prevalence , Recombinant Fusion Proteins/adverse effects , Risk Factors , Severity of Illness Index , Spain , Stents/adverse effects , Time Factors , Treatment Outcome , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/virology
3.
Transplant Proc ; 44(9): 2601-2, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146468

ABSTRACT

Hypertension is common following renal transplantation, affecting up to 80% of transplant recipients. It is generally accepted that hypertension is associated with poor graft survival and reduced life expectancy, contributing to increased cardiovascular risk factors and mortality rates. The aim of the study was to compare the blood pressure (BP) control in kidney transplant patients through the use of ambulatory BP monitoring (ABMP) versus office BP measurements (oBP). A multicenter, cross-sectional, observational study was conducted in 30 nephrology/kidney transplant units. Eligible patients included hypertensive cadaveric kidney transplant recipients aged <70 years, with a functioning kidney for at least 1 year and with an estimated glomerular filtration ≥30 mL/min/1.73 m(2) and a serum creatinine < 2.5 mg/dL. Recorded data included demographic characteristics, oBP, and ABPM and labroatory investigations. The 868 patients showed a mean recipient age of was 53.2 ± 11.6 years and mean follow-up after transplantation, 5.5 ± 2.8 years. Mean systolic and diastolic oBP were 140.2 ± 18 and 80.4 ± 10 mm Hg, respectively. Seventy-six percent of patients had oBP higher than or equal to 130/80 mm Hg. Mean 24 hour ABPM were 131.5 ± 14 and 77.4 ± 8.7 mm Hg for systolic and diastolic BP, respectively. Using the ABPM, we observed that 36.5% of subjects were controlled (mean 24-hour BP < 130/85 mm Hg). The two methods (oBP and ABPM) showed significant agreement. After ABPM, 65% of patients diagnosed as true controlled hypertension were considered to have white-coat RH. In clinical practice ABPM may help for better adjustment of drugs for adequate BP control.


Subject(s)
Blood Pressure Monitoring, Ambulatory , Blood Pressure , Hypertension/diagnosis , Kidney Transplantation/adverse effects , Adult , Aged , Antihypertensive Agents/therapeutic use , Biomarkers/blood , Blood Pressure/drug effects , Creatinine/blood , Cross-Sectional Studies , Glomerular Filtration Rate , Humans , Hypertension/drug therapy , Hypertension/etiology , Hypertension/physiopathology , Middle Aged , Office Visits , Predictive Value of Tests , Spain , Time Factors , White Coat Hypertension/diagnosis , White Coat Hypertension/etiology , White Coat Hypertension/physiopathology
4.
Transplant Proc ; 40(9): 2912-5, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19010145

ABSTRACT

Impaired cardiac structure and function are fundamental components of cardiovascular disease, leading to morbidity, mortality, and graft loss after renal transplantation. The aim of this study was to describe and determine the factors involved in these cardiac abnormalities, paying special attention to the role of glucose metabolism and oxidative stress. We studied 54 long-term, nondiabetic recipients with no valvulopathy who underwent an echocardiographic examination and simultaneous biochemical determinations of lipid profile, hemoglobin A1c (HbA1c), and various oxidative stress parameters: malondialdehyde, superoxide dismutase, total glutathione, and isoprostanes. We calculated the left ventricular mass index (LVMI) and ejection fraction and the peak velocity of early rapid filling to peak velocity of atrial filling (E/A) ratio. Left ventricular hypertrophy (LVH), systolic dysfunction, and diastolic dysfunction (LVDD) were present in 25.9%, 5.6%, and 59.25% of the patients, respectively. The mean blood pressure (MBP) was higher and the hemoglobin lower among patients with LVH, which was related to the age of the patients. We observed a significant negative association of the E/A ratio-used as an index of LVDD-with HbA1c (r = -.448, P = .002) and age (r = -.57, P = .000) and a positive association with the level of total glutathione (r = .322, P = .029). Multiple regression analysis of the E/A ratio showed significance only for HbA1c but not for MBP or LVMI. These results suggested a possible causal influence of subclinical glucose metabolism impairment as detected by HbA1c on the presentation of LVDD via the impaired oxidative stress status, independent of blood pressure control or LVH grade.


Subject(s)
Blood Glucose/metabolism , Cardiovascular Diseases/epidemiology , Kidney Transplantation/physiology , Oxidative Stress , Ventricular Function, Left/physiology , Adult , Aged , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Blood Pressure , Diastole/physiology , Electrocardiography , Female , Follow-Up Studies , Glycated Hemoglobin/analysis , Heart Atria/physiopathology , Humans , Hypertension/epidemiology , Hypertrophy, Left Ventricular/epidemiology , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/adverse effects , Kidney Transplantation/immunology , Male , Middle Aged , Postoperative Complications/epidemiology , Systole/physiology , Time Factors
5.
Nutr Hosp ; 7(1): 52-7, 1992.
Article in Spanish | MEDLINE | ID: mdl-1554787

ABSTRACT

The evaluation of the nutritional state of patients on maintenance haemodialysis is one of the main aspects involved in the prescription of treatment, since malnutrition is frequent among these patients and is a very important risk factor. We studied the albumin levels and the levels of several rapid interchange proteins (prealbumin, transferrin, cholinesterase) in 106 patients with chronic renal failure on haemodialysis. The proteic catabolism rate (pcr) and total dose on normalized dialysis (KT/V) was also determined in these patients, in accordance with the kinetic urea model. Anthropometrical measurements were taken (dry weight following haemodialysis, skin fold of the triceps and muscular circumference of the arm) in 65 patients. The average levels of the proteins studied were within normal laboratory limits, except for albumin, which was slightly lower. The greater frequency of infranormal levels corresponded to albumin (57%); the protein least altered was prealbumin (14.7%), although 70.4% of patients showed lower levels of this protein compared to those considered as indicating a poor prognosis (30 mg/day). The estimated daily proteic intake, according to the proteic catabolism rate, was lower than the recommended rate in 58% of our patients, this was not correlated with any of the proteins studied, and was significantly lower in the group of patients whose dialysis dose was too low. Although the anthropomorphic parameters did not correlate with any protein, the average levels of prealbumin were significantly lower in patients with infranormal levels of dry weight and skin fold of the triceps. The albumin, prealbumin, transferrin and cholineserase levels were not affected by treatment with erithropoyetin, haemodialysis buffer bath or type of membrane used.


Subject(s)
Blood Proteins/analysis , Kidney Failure, Chronic/blood , Nutrition Assessment , Renal Dialysis , Adult , Aged , Aged, 80 and over , Anthropometry , Female , Humans , Kidney Failure, Chronic/therapy , Male , Middle Aged , Nutritional Status
SELECTION OF CITATIONS
SEARCH DETAIL
...